STOCK TITAN

DSS, Inc. 8-K Filings

DSS NYSE

Every 8-K that DSS, Inc. (DSS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow DSS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DSS filings page.

Rhea-AI Summary

DSS, Inc. (DSS) entered into a related-party securities purchase agreement with Alset Inc. under which Alset loaned DSS $500,000 in exchange for a convertible promissory note and warrants for up to 8,000,000 common shares. The note carries 3% simple interest and is payable on demand, with a five-year maturity.

Alset may convert principal and interest into common stock at $0.50 per share, and the warrants are exercisable at $0.55 per share for five years. Conversion of the note and exercise of the warrants both require stockholder approval. DSS and Alset are under common control through Chairman Chan Heng Fai, and the board and audit committee approved the transaction.

Rhea-AI Summary

DSS, Inc. entered into a material definitive financing agreement with Alset, Inc., under which Alset will loan DSS $1,000,000 in exchange for a convertible promissory note and stock warrants.

The note carries simple interest of 3% per year and matures five years from issuance. Alset may convert principal and accrued interest into DSS common stock at $0.45 per share. Separately, Alset receives warrants to purchase up to 17,777,776 DSS shares at an exercise price of $0.50 per share, expiring three years from issuance.

The deal is a related party transaction because DSS and Alset are under common control of Chan Heng Fai and share overlapping directors. The agreements were approved by DSS’s board and, where applicable, its audit committee, with interested directors recusing themselves.

Rhea-AI Summary

DSS, Inc. entered into a material securities purchase agreement with Alset International Limited under which Alset International will loan DSS $2,450,000 via a convertible promissory note and receive warrants.

The note bears simple interest at 3% per year and may be converted into common stock at $0.74 per share any time before its five-year maturity. The accompanying warrants allow Alset International to buy up to 16,554,055 DSS common shares at an exercise price of $0.93 per share, expiring five years from issuance.

The transaction is a related-party deal because both companies are under the common control of Chan Heng Fai and share several directors, and it is subject to stockholder approval and board and audit committee oversight.

Rhea-AI Summary

DSS, Inc. completed a firm-commitment underwritten public offering of 900,000 shares of common stock at $1.00 per share. After underwriting discounts, commissions and expenses, the company expects to receive net proceeds of approximately $0.7 million.

DSS granted the underwriter, Aegis Capital Corp., a 45-day option to buy up to an additional 135,000 shares to cover over-allotments. The offering, conducted under an effective Form S-3 shelf registration, closed on February 5, 2026. DSS plans to use the proceeds for general corporate purposes and working capital, and its executives and directors agreed to a 45-day lock-up on share sales.

Rhea-AI Summary

DSS, Inc. reported the results of its 2025 annual meeting of stockholders held on December 3, 2025. A total of 9,092,518 shares of common stock, representing 83.80% of shares outstanding and eligible to vote as of October 6, 2025, were present in person or by proxy, establishing a quorum.

Stockholders elected all seven director nominees — Ambrose Chan Heng Fai, José Escudero, Wai Leung William Wu, Tung Moe Chan, Hiu Pan Joanne Wong, Shui Yeung Frankie Wong, and Lim Sheng Hon Danny — to serve until the next annual meeting. They also ratified the appointment of HTL International, LLC as independent registered public accounting firm for the fiscal year ending December 31, 2025, with 7,401,486 votes for, 178,858 against and 39,793 abstentions.

In addition, stockholders approved, on an advisory basis, the compensation of the company’s named executive officers, with 6,214,296 votes for, 31,186 against and 8,073 abstentions, plus 1,366,582 broker non-votes.

8-K
8-K